Clinical trial
Ixekizumab in the Treatment of Bullous Pemphigoid
NCT03099538 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ixekizumab in the Treatment of Bullous Pemphigoid
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 15, 2017
- Completion date
- June 6, 2019
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bullous pemphigoid, pemphigoid